Jain, Akriti G

Major adverse cardiovascular events (MACE) in cancer patients treated with tirzepatide compared to GLP-1 receptor agonists: A target trial emulation using real-world data.

Ashruf, O., Mushtaq, A., Lin, C. (.-T., Volk, M., Orozco, Z., Hundal, J., Safdar, A., Thompson, C., Karimi, S., Jain, A. G., et al. (2025) · Journal of Clinical Oncology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 4